The entity reports 36.61
B of total liabilities with total debt to equity ratio (D/E) of 0.76, which is normal for its line of buisiness.
What is the right price you would pay to acquire a share of Cigna Corp? For most investors, it would be the price that gives them a wide margin of safety to have minimal downside risk. In other words, most investors are always looking for undervalued stocks. Even if the
future performance is not entirely as expected, the loss of holding it is minimized, and the downside risk is negated. Please read more on our
stock advisor page.
What is happening with Cigna Corp this year
Annual and quarterly reports issued by Cigna Corp are formal
financial statements that are published yearly and quarterly and sent to Cigna stockholders. The reports show and break down the current year's ongoing operations and discuss plans for the upcoming year. Annual reports have been a requirement from the
Securities and Exchange Commission (SEC) for businesses owned by the public since 1934.
Companies such as Cigna Corp often view their annual report as an effective marketing tool to disseminate their perspective on company
future earnings or innovations. With this in mind, many companies devote large sums of money to making their reports attractive and informative. In such instances, the annual report becomes a forum through which a company can communicate to the general public any number of topics that may or may not be directly related to the actual data published in the reports.
Cigna Corp Gross Profit
Cigna Corp Gross Profit growth is one of the most critical measures in evaluating the company. The Gross Profit growth rate is calculated simply by comparing Cigna Corp previous period's values with its current period's values. Each time period you're measuring should be of equal lengths the increase or decrease, in a company's Gross Profit between two periods. Here we show Cigna Corp Gross Profit growth over the last 10 years. Please check Cigna Corp's
gross profit and other
fundamental indicators for more details.
Breaking down the case for Cigna Corp
Earning per share calculations of Cigna is based on official Zacks consensus of 8 analysts regarding Cigna's future annual earnings. Given the historical accuracy of 93.05%, the future earnings per share of the company is estimated to be 18.56 with the lowest and highest values of 18.45 and 18.63, respectively. Please note that this consensus of annual earnings estimates for the firm is an estimate of EPS before non-recurring items and including employee stock options expenses.
Is Cigna a risky opportunity?
Let's check the volatility. Cigna is looking slightly risky at this time. Whether you invest your money or manage your clients' funds, remember that it is easy to forget that behind Cigna (NYSE:CI) stock is an actual business venture. So, do not let stock picking become an abstract concept by ignoring the elementary risk calculations. locking in a share of a Cigna stock makes you a part-owner of that company.
Cigna Current Consensus
Here is the current trade recommendation based on an ongoing consensus estimate among financial analysis covering Cigna. The Cigna consensus assessment is calculated by taking the average estimates from all of the analysts covering Cigna
| Strong Buy | 13 | 81.25 |
| Buy | 2 | 12.5 |
| Hold | 1 | 6.25 |
| Sell | 0 | 0.0 |
| Strong Sell | 0 | 0.0 |
Another 3 percent drop for Cigna
Current Total Risk Alpha is up to -0.06. Price may drop again. As of the 4th of February, Cigna shows the Mean Deviation of 1.91,
downside deviation of 1.83, and Risk Adjusted Performance of 0.145. Cigna
technical analysis gives you the methodology to make use of
historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of
historical prices and volume momentum, or the prices will eventually revert. We were able to analyze nineteen
technical drivers for Cigna, which can be compared to its rivals. Please confirm
Cigna coefficient of variation,
maximum drawdown,
skewness, as well as the
relationship between the
information ratio and
downside variance to decide if Cigna is priced correctly, providing market reflects its regular price of 210.86 per share. Given that Cigna has
jensen alpha of 0.2311, we suggest you to validate Cigna's prevailing market performance to make sure the company can sustain itself at a future point.
Our Final Take On Cigna
While some other entities in the healthcare plans industry are either recovering or due for a correction, Cigna may not be as strong as the others in terms of longer-term growth potentials. While some stockholders may not share our view, we believe it may be a good time to increase your existing holdings in Cigna. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to Cigna.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectEditorial Staff
Ellen Johnson is a Member of Macroaxis Editorial Board. Ellen covers public companies in North America, focusing primarily on valuation and volatility. Six years of experience in predictive investment analytics and risk management.
View Profile This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Ellen Johnson do not own shares of Cigna Corp. Please refer to our
Terms of Use for any information regarding our disclosure principles.
Would you like to provide feedback on the content of this article?
You can get in touch with us directly or send us a quick note via email to
editors@macroaxis.com
